Zheng Yan

Zheng Yan

Company: Novartis AG

Job title: Principle scientist

Seminars:

Preclinical to Clinical Development: Targeting the NLRP3 Inflammasome in Myelodysplastic Syndrome 8:30 am

NLRP3 inflammasome is constitutively active in myelodysplastic syndrome (MDS) Novartis is starting clinical trials to assess the impact of anti-inflammatory molecules in low-risk MDSRead more

day: Conf Day 1

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.